Literature DB >> 19381138

Crohn's disease-associated Nod2 mutants reduce IL10 transcription.

Dana J Philpott, Stephen E Girardin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19381138     DOI： 10.1038/ni0509-455

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  14 in total

1.  Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB.

Authors:  Y Ogura; N Inohara; A Benito; F F Chen; S Yamaoka; G Nunez
Journal:  J Biol Chem       Date:  2000-11-21       Impact factor: 5.157

2.  The frameshift mutation in Nod2 results in unresponsiveness not only to Nod2- but also Nod1-activating peptidoglycan agonists.

Authors:  Mihai G Netea; Gerben Ferwerda; Dirk J de Jong; Catherine Werts; Ivo G Boneca; Muguette Jéhanno; Jos W M Van Der Meer; Dominique Mengin-Lecreulx; Philippe J Sansonetti; Dana J Philpott; Sébastien Dharancy; Stephen E Girardin
Journal:  J Biol Chem       Date:  2005-08-22       Impact factor: 5.157

3.  Predictive value of the CARD15 variant 1007fs for the diagnosis of intestinal stenoses and the need for surgery in Crohn's disease in clinical practice: results of a prospective study.

Authors:  Julia Seiderer; Stephan Brand; Karin A Herrmann; Fabian Schnitzler; Rudolf Hatz; Alexander Crispin; Simone Pfennig; Stefan O Schoenberg; Burkhard Göke; Peter Lohse; Thomas Ochsenkuhn
Journal:  Inflamm Bowel Dis       Date:  2006-12       Impact factor: 5.325

Review 4.  Inflammatory bowel disease: clinical aspects and established and evolving therapies.

Authors:  Daniel C Baumgart; William J Sandborn
Journal:  Lancet       Date:  2007-05-12       Impact factor: 79.321

Review 5.  Function of Nod-like receptors in microbial recognition and host defense.

Authors:  Luigi Franchi; Neil Warner; Kyle Viani; Gabriel Nuñez
Journal:  Immunol Rev       Date:  2009-01       Impact factor: 12.988

6.  RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs.

Authors:  Jong-Hwan Park; Yun-Gi Kim; Christine McDonald; Thirumala-Devi Kanneganti; Mizuho Hasegawa; Mathilde Body-Malapel; Naohiro Inohara; Gabriel Núñez
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

7.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

8.  Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing.

Authors:  Shin Maeda; Li-Chung Hsu; Hongjun Liu; Laurie A Bankston; Mitsutoshi Iimura; Martin F Kagnoff; Lars Eckmann; Michael Karin
Journal:  Science       Date:  2005-02-04       Impact factor: 47.728

9.  Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease.

Authors:  Naohiro Inohara; Yasunori Ogura; Ana Fontalba; Olga Gutierrez; Fernando Pons; Javier Crespo; Koichi Fukase; Seiichi Inamura; Shoichi Kusumoto; Masahito Hashimoto; Simon J Foster; Anthony P Moran; Jose L Fernandez-Luna; Gabriel Nuñez
Journal:  J Biol Chem       Date:  2003-01-04       Impact factor: 5.157

10.  Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.

Authors:  Stephen E Girardin; Ivo G Boneca; Jérôme Viala; Mathias Chamaillard; Agnès Labigne; Gilles Thomas; Dana J Philpott; Philippe J Sansonetti
Journal:  J Biol Chem       Date:  2003-01-13       Impact factor: 5.157
View more
  12 in total

1.  Intracellular pathogen sensor NOD2 programs macrophages to trigger Notch1 activation.

Authors:  Kushagra Bansal; Kithiganahalli N Balaji
Journal:  J Biol Chem       Date:  2010-12-14       Impact factor: 5.157

Review 2.  The microbiome in inflammatory bowel disease: current status and the future ahead.

Authors:  Aleksandar D Kostic; Ramnik J Xavier; Dirk Gevers
Journal:  Gastroenterology       Date:  2014-02-19       Impact factor: 22.682

3.  Variation in NOD2 augments Th2- and Th17 responses to myelin basic protein in multiple sclerosis.

Authors:  Chris Juul Hedegaard; Christian Enevold; Finn Sellebjerg; Klaus Bendtzen; Claus Henrik Nielsen
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

4.  The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease.

Authors:  Parth J Parekh; Luis A Balart; David A Johnson
Journal:  Clin Transl Gastroenterol       Date:  2015-06-18       Impact factor: 4.488

5.  Membrane Association Dictates Ligand Specificity for the Innate Immune Receptor NOD2.

Authors:  Amy K Schaefer; James E Melnyk; Michael M Baksh; Klare M Lazor; M G Finn; Catherine Leimkuhler Grimes
Journal:  ACS Chem Biol       Date:  2017-07-25       Impact factor: 5.100

Review 6.  The microbiota in inflammatory bowel disease: current and therapeutic insights.

Authors:  Erin R Lane; Timothy L Zisman; David L Suskind
Journal:  J Inflamm Res       Date:  2017-06-10

Review 7.  Pharmacogenetics in inflammatory bowel disease: understanding treatment response and personalizing therapeutic strategies.

Authors:  Jesús K Yamamoto-Furusho
Journal:  Pharmgenomics Pers Med       Date:  2017-05-26

Review 8.  Recipe for IBD: can we use food to control inflammatory bowel disease?

Authors:  Mario Witkowski; Marco Witkowski; Nicola Gagliani; Samuel Huber
Journal:  Semin Immunopathol       Date:  2017-11-09       Impact factor: 9.623

9.  NOD2 Polymorphisms and Their Impact on Haematopoietic Stem Cell Transplant Outcome.

Authors:  Neema P Mayor; Bronwen E Shaw; J Alejandro Madrigal; Steven G E Marsh
Journal:  Bone Marrow Res       Date:  2012-10-18

10.  Nucleotide-binding oligomerization domain-containing protein 2 prompts potent inflammatory stimuli during Neospora caninum infection.

Authors:  Marcela Davoli-Ferreira; Denise M Fonseca; Caroline M Mota; Murilo S Dias; Djalma S Lima-Junior; Murilo V da Silva; Gustavo F S Quirino; Dario S Zamboni; João S Silva; Tiago W P Mineo
Journal:  Sci Rep       Date:  2016-07-05       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.